| Literature DB >> 28991153 |
Charles A Osunla1,2,3, Anthony I Okoh4,5.
Abstract
Members of the Vibrio genus are autochthonous inhabitants of aquatic environments and play vital roles in sustaining the aquatic milieu. The genus comprises about 100 species, which are mostly of marine or freshwater origin, and their classification is frequently updated due to the continuous discovery of novel species. The main route of transmission of Vibrio pathogens to man is through drinking of contaminated water and consumption inadequately cooked aquatic food products. In sub-Saharan Africa and much of the developing world, some rural dwellers use freshwater resources such as rivers for domestic activities, bathing, and cultural and religious purposes. This review describes the impact of inadequately treated sewage effluents on the receiving freshwater resources and the associated risk to the rural dwellers that depends on the water. Vibrio infections remain a threat to public health. In the last decade, Vibrio disease outbreaks have created alertness on the personal, economic, and public health uncertainties associated with the impact of contaminated water in the aquatic environment of sub-Saharan Africa. In this review, we carried out an overview of Vibrio pathogens in rural water resources in Sub-Saharan Africa and the implication of Vibrio pathogens on public health. Continuous monitoring of Vibrio pathogens among environmental freshwater and treated effluents is expected to help reduce the risk associated with the early detection of sources of infection, and also aid our understanding of the natural ecology and evolution of Vibrio pathogens.Entities:
Keywords: Vibrio pathogens; public health; rural water resources; sub-Saharan Africa
Mesh:
Substances:
Year: 2017 PMID: 28991153 PMCID: PMC5664689 DOI: 10.3390/ijerph14101188
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Some disease conditions initiated by pathogenic Vibrio species.
| Diarrhea | Cholera | Septicemia | Skin-infection | Others * | |
| - | ## | - | - | ≠ | |
| ## | # | # | ≠ | ||
| - | ≠ | ## | ≠ | ||
| - | ## | ## | - | ||
| ## | - | - | - | ||
| ≠ | - | - | ≠ | ||
| ## | - | - | ≠ | ||
| ## | ## | ## | ≠ | ||
| ≠ | ## | ## | ≠ | ||
## key infections; # minor infections; ≠ random infections. * includes otitis media cholesystitis, meningitis. Adapted from [49].
Biochemical characterization of some Vibrio species.
| Caption | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TCBC agar | YLW | GRN | YLW | YLW | GRE | YLW | YLW | GRE | ABS | GRE | GRE |
| mCPC agar | Purple | ABS | ABS | ABS | YLW | ABS | NOTD | ABS | ABS | ABS | ABS |
| AGS | AKa | AKa | AKAK | AKAK | AKa | AKa | NOTD | NAD | Aka | AKAK | AKa |
| Grth. NaCl (0%) | + | − | − | − | − | − | − | − | − | − | + |
| Grth. NaCl (3%) | + | + | + | + | + | + | + | + | + | + | + |
| Grth .NaCl (6%) | − | + | + | + | + | + | + | V | + | + | − |
| Grth NaCl (8%) | − | + | V | + | − | + | − | − | − | V | − |
| Grth. NaCl (10%) | − | − | − | − | − | + | − | − | − | − | − |
| Grth at 42 °C | + | + | V | - | + | + | − | − | NOTD | V | + |
| CA | NOTD | + | − | NOTD | + | − | NOTD | NOTD | NOTD | NOTD | NOTD |
| VP | NOTD | - | - | NOTD | - | + | NOTD | NOTD | NOTD | NOTD | NOTD |
| SU | + | − | + | + | − | + | + | − | − | + | − |
| CE | − | V | + | − | + | − | + | + | − | − | − |
| LA | − | − | − | − | − | − | − | − | − | − | − |
| AB | − | − | + | + | − | + | − | + | − | − | |
| MA | + | + | + | + | + | + | + | + | + | + | + |
| MA | + | + | + | + | Va | + | − | − | + | + | + |
| OX | + | + | + | + | + | + | + | + | + | − | + |
| Ad | − | − | + | + | − | − | - | + | + | − | |
| Ld | + | + | − | − | + | + | + | − | − | + | + |
| Od | + | + | − | − | + | + | − | − | − | − | + |
| S 0/129 (10 μg) | SNTIVE | REST | REST | REST | SNTIVE | REST | SNTIVE | SNTIVE | NAD | SNTIVE | SNTIVE |
| S 0/129 150 μg) | SNTIVE | SNTIVE | SNTIVE | SNTIVE | SNTIVE | SNTIVE | SNTIVE | SNTIVE | NAD | SNTIVE | SNTIVE |
| GE | + | + | + | + | + | + | − | + | − | + | + |
| UR | − | V | − | − | − | − | − | + | − | − | − |
Note: AGS—arginine-glucose slant; Grth—Growth; CA—Capsule; VP—Voges-Proskauer; SU—Sucrose; CE—Cellobiose; LA—Lactose; AB—Arabinose; MA—Mannitol; OX—Oxidase; Ad—Arginine dihydrolase; Ld—Lysine decarboxylase; Od—Ornithine decarboxylase; GE—Gelatinase; UR—Urease; AC—Acid; AK—Alkaline; Va—Variable reaction; a—slight acid; ABS—Absence of growth; GRE—green; YEL—yellow; NOTD—Not determined; SNTIVE—Sensitive; REST—Resistant. Adapted from [40,41].
Some proteolytic enzymes produced by pathogenic Vibrio species. Adapted from [49,123].
| Vibrolysin | Collagenase | Chymotrypsin-Like Protease | Haemolysin | |
|---|---|---|---|---|
| Present | Present | |||
| Present | Present | Present | ||
| Present | ||||
| Present | Present | |||
| Present | Present | |||
| Present | Present | |||
| Present | ||||
| Present | ||||
| Present |
Epidemiological updates of cholera outbreaks from 10 selected countries in Sub-Saharan Countries between 1994 and 2016. Adapted from [152].
| Name of Countries | Cases between (1994–2013) | Cases in 2014 | Cases in 2015 | Cases in 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | Cases | Death | CFR | Cases | Death | CFR | Cases | Death | CFR | Cases | Death | CFR | |
| Nigeria | 2004–2013 | 105,483 | 3913 | 3.7 | 35,996 | 755 | 02 | 5913 | 188 | 3.2 | 768 | 32 | 4.2 |
| Cameroun | 2004–2013 | 46,172 | 1817 | 3.9 | 3355 | 184 | 05 | 120 | 5 | 4.2 | 77 | 1 | 1.2 |
| Niger | 1994–3013 | 21,538 | 978 | 4.5 | 2059 | 80 | 04 | 51 | 4 | 7.8 | 38 | 5 | 13.2 |
| Lake Chad Basin | 2004–2013 | 31,918 | 996 | 3.2 | 41,188 | 994 | 2.4 | 6084 | 197 | 3.2 | 883 | 38 | 4.3 |
| Ghana | 1998–2013 | 55,784 | 1095 | 2 | 28,944 | 247 | 01 | 687 | 10 | 1.5 | 600 | 00 | 00 |
| Benin | 2004–2013 | 5432 | 48 | 0.9 | 874 | 14 | 02 | 00 | 00 | 00 | 874 | 13 | 1.5 |
| Togo | 2006–2013 | 2142 | 38 | 1.8 | 329 | 11 | 03 | 50 | 02 | 4.0 | 02 | 00 | 00 |
| Cote d’Ivoire | 2002–2013 | 7573 | 272 | 3.6 | 248 | 14 | 06 | 200 | 02 | 1.0 | 16 | 01 | 06 |
| Guinea Bissau | 1996–2013 | 74,031 | 1684 | 2.3 | 18 | 3 | 7 | 00 | 00 | 00 | 00 | 00 | 00 |
| DR Congo | - | - | - | - | 19,305 | 265 | 01 | 18,403 | 272 | 1.5 | 28,162 | 772 | 2.7 |
Note: The risk factors for cholera outbreaks in the 10 selected countries in sub-Saharan Countries between 1994 and 2016 are poor sanitation, lack of safe water and cross border.
Selected drug-resistant Vibrio species strains reported in Sub-Saharan Africa. Adapted from [209] with slight modification.
| Year | Country | Strain | Antibiotic Resistance | Mechanism | Reference |
|---|---|---|---|---|---|
| 2006 | Accra, Ghana | O1 | SXT | SXT element, Class 2 integron, Class 1 integron. | [ |
| 2011–2014 | Ghana | O1 biotype El Tor | Am, Cpr, NA, SXT. | ND | [ |
| Nov. 2002–April 2004 | Mozambique | O1 El Tor Ogawa | Cm, Co, Tet, Qu. | ND | [ |
| 1994 | Rwanda | O1 EL Tor | Co | ND | [ |
| Oct. 2004–Mar. 2006 | Senegal | O1 El Tor | Co | ND | [ |
| 2009–2010 | Nigeria | atypical El Tor | SXT, Spec | ND | [ |
| 2004–2005 | Cameroun | O1 | SXT, Amp | ND | [ |
| Aug. 2006–Sep. 2008 | North-west Ethiopia | O1 Inaba | Co, Cm, Amp, Ery, Tet, Cpr. | ND | [ |
| 2011–2012 | DR Congo | Ogawa and Inaba | NA, Am, Cm, Tet, Do, Nf, SXT, Ery. | ND | [ |
| Dec. 2006–Feb. 2007 | Namibia | O1 El Tor Inaba | SXT, Sm. | ND | [ |
| 1998–1999 | Kenya | O1 | Spec, Cm, Co, Tet | ND | [ |
| 2006 | Angola | O1 and | Am, Cm, Tri, SXT, Tet. | Plasmid located Class 1 integrons. | [ |
| 2010 | South Africa | Vf (Tri, Pen, Co, Spec). V spp. (Am and SXT). | ND | [ | |
| 2008–2009 | South Africa | O1 Inaba | Co, NA, Am, Tet, Cm, Ery, Ce. | Tet A gene, SXT element-integrase | [ |
Note: Am: amoxicillin; Amp: ampicillin; Cm: chloramphenicol; Co: cotrimoxazole; Cpr: ciprofloxacin; Ery: erythromycin; Spec: spectinomycin; SXT: sulfamethoxazole–trimethoprim; Tet: tetracycline; Tri: trimethoprim; NA: nalidixic acid; Qu: quinolone; Sm: streptomycin; pen: penicillin; Ce: cephalosporin.